The influence of age on the development of the hepatitis B carrier state-Reference-Cited by-同舟云学术

The influence of age on the development of the hepatitis B carrier state

Published:1993-08-23 Issue:1337 Volume:253 Page:197-201
ISSN:0962-8452
Container-title:Proceedings of the Royal Society of London. Series B: Biological Sciences
language:en
Short-container-title:Proc. R. Soc. Lond. B

Author:

Publisher

The Royal Society

Subject

General Agricultural and Biological Sciences,General Environmental Science,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://royalsocietypublishing.org/doi/pdf/10.1098/rspb.1993.0102

Reference26 articles.

1. Anderson R. M. & May R. M. 1991 Infectious diseases of humans.Oxford University Press.

2. Beasley R. P. Hwang L.-Y. Lin C.-C. Stevens C. E. Wang K.-Y. Sun T.-S. Hsieh F.-J. & Szmuness W. 1981 Hepatitis B immune globulin (HBIg) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet (ii) 388-393.

3. INCIDENCE OF HEPATITIS AMONG STUDENTS AT A UNIVERSITY IN TAIWAN

4. Immune response to hepatitis B virus in children with papular acrodermatitis;Colombo M.;Gastroenterology,1977

5. Ageand sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J. med;Coursaget P.;Virol.,1987

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBV prevalence in Sub-continental countries: A systematic review and meta-analysis;PLOS ONE;2023-12-08

2. Characterization of differential susceptibility and differential infectivity epidemic models;Journal of Mathematical Biology;2023-11-27

3. Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people;Gut;2023-10-05

4. A global investment case for hepatitis B elimination: a modelling study;The Lancet Gastroenterology & Hepatology;2023-10

5. Is It Time for Treatment as Prevention of Chronic Hepatitis B?;Pathogens;2023-09-06